Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Schulz

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Anticancer Research|November 29, 2025
Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: A Single-institutional Real-world StudyRalph Muecke, Khashayar Fakhrian, Robert Gosenheimer, et al.
Oncology|April 22, 2008
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancerStefan Boeck, Ralf Wilkowski, Christiane J Bruns, et al.
Journal of Cancer Research and Clinical Oncology|January 15, 2013
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapyMichael Haas, Volker Heinemann, Frank Kullmann, et al.
Journal of Cellular Physiology|June 21, 2005
Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cellsAlbrecht Schwab, Andrea Wulf, Christoph Schulz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 9, 2015
Preoperative serum markers for individual patient prognosis in stage I-III colon cancerClemens Giessen-Jung, Dorothea Nagel, Maria Glas, et al.
Annals of Hematology|January 9, 2019
Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysisMaximilian Doppelhammer, Alessia Fraccaroli, Dusan Prevalsek, et al.
Clinical Colorectal Cancer|July 7, 2011
Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancerClemens Giessen, Sebastian Stintzing, Ruediger Paul Laubender, et al.
BMC Gastroenterology|February 11, 2016
Mortality Risk for Acute Cholangitis (MAC): a risk prediction model for in-hospital mortality in patients with acute cholangitisJochen Schneider, Alexander Hapfelmeier, Sieglinde Thöres, et al.
American Journal of Hematology|September 9, 2018
Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDSAlessia Fraccaroli, Dusan Prevalsek, Susanne Fritsch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 10, 2023
Radiation therapy of breast cancer in the Nahe Breast Center: first results of an analysis in the context of health services researchRalph Mücke, Gabor Heim, Robert Gosenheimer, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Anticancer Research|November 29, 2025
Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: A Single-institutional Real-world StudyRalph Muecke, Khashayar Fakhrian, Robert Gosenheimer, et al.
Oncology|April 22, 2008
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancerStefan Boeck, Ralf Wilkowski, Christiane J Bruns, et al.
Journal of Cancer Research and Clinical Oncology|January 15, 2013
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapyMichael Haas, Volker Heinemann, Frank Kullmann, et al.
Journal of Cellular Physiology|June 21, 2005
Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cellsAlbrecht Schwab, Andrea Wulf, Christoph Schulz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 9, 2015
Preoperative serum markers for individual patient prognosis in stage I-III colon cancerClemens Giessen-Jung, Dorothea Nagel, Maria Glas, et al.
Annals of Hematology|January 9, 2019
Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysisMaximilian Doppelhammer, Alessia Fraccaroli, Dusan Prevalsek, et al.
Clinical Colorectal Cancer|July 7, 2011
Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancerClemens Giessen, Sebastian Stintzing, Ruediger Paul Laubender, et al.
BMC Gastroenterology|February 11, 2016
Mortality Risk for Acute Cholangitis (MAC): a risk prediction model for in-hospital mortality in patients with acute cholangitisJochen Schneider, Alexander Hapfelmeier, Sieglinde Thöres, et al.
American Journal of Hematology|September 9, 2018
Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDSAlessia Fraccaroli, Dusan Prevalsek, Susanne Fritsch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 10, 2023
Radiation therapy of breast cancer in the Nahe Breast Center: first results of an analysis in the context of health services researchRalph Mücke, Gabor Heim, Robert Gosenheimer, et al.
Pageof 6